Editorials (Stem Cell Tourism in the Era of Personalized Medicine: What We Know, and What We Need to Know)

E-ISSN： 1875-6913|10|2|106-110

ISSN： 1875-6921

Source： Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol.10, Iss.2, 2012-06, pp. : 106-110

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Assays and applications in warfarin metabolism: what we know, how we know it and what we need to know

By Jones Drew R Miller Grover P

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 7, 2011-07 ,pp. : 857-874

Informa Healthcare

Access to resources Recommend Favorite

WHAT WE KNOW AND WHAT WE NEED TO KNOW ABOUT DEVELOPMENTAL ALUMINUM TOXICITY

By Golub Mari S. Domingo Jose L.

Journal of Toxicology and Environmental Health, Vol. 48, Iss. 6, 1996-08 ,pp. : 585-598

Taylor & Francis Ltd

Access to resources Recommend Favorite

Idarucizumab: What Should We Know?

Current Drug Targets, Vol. 19, Iss. 1, 2018-01 ,pp. : 81-88

Bentham Science Publishers

Access to resources Recommend Favorite

ACE Inhibitors in Heart Failure: What More Do We Need to Know?

By Demers Catherine Mody Anita Teo Koon K. McKelvie Robert S.

American Journal of Cardiovascular Drugs, Vol. 5, Iss. 6, 2005-01 ,pp. : 351-359

Adis International

Access to resources Recommend Favorite

Adenosine Receptors: What We Know and What We are Learning

Current Topics in Medicinal Chemistry, Vol. 10, Iss. 9, 2010-06 ,pp. : 860-877

Bentham Science Publishers

Access to resources Recommend Favorite